中华微生物学和免疫学杂志
中華微生物學和免疫學雜誌
중화미생물학화면역학잡지
CHINESE JOURNAL OF MICROBIOLOGY AND IMMUNOLOGY
2011年
3期
208-212
,共5页
王艳艳%刘红%杜昕%李刚%魏取好%陈晓耘%蒋晓飞
王豔豔%劉紅%杜昕%李剛%魏取好%陳曉耘%蔣曉飛
왕염염%류홍%두흔%리강%위취호%진효운%장효비
泛耐药%肺炎克雷伯菌%多位点序列分型%PCR
汎耐藥%肺炎剋雷伯菌%多位點序列分型%PCR
범내약%폐염극뢰백균%다위점서렬분형%PCR
Panresistance%Klebsiella pneumoniae%Multilocus sequence typing%PCR
目的 了解华山医院泛耐药肺炎克雷伯菌株及其流行的特点.方法 收集2006年8月-2009年12月对CLSI推荐常规检测药物均耐药的肺炎克雷们菌临床分离株,共57株.所有菌株都进行药物敏感试验、超广谱β-内酰胺酶(ESBLs)初筛及表型确证试验、改良Hodge试验、等电聚焦电泳,聚合酶链反应及其产物测序、接合试验、肠杆菌基因间重复共有序列PCR(ERIC-PCR)和多位点序列分型(MLST).结果 所有菌株都携带blaKPC-2、blaCTX-M-14、blaSHV12和blaTEM-1及qnrB和aac(6')-I b-cr基因.57株细菌中ST423型5株,MIST ST11型52株.ST423型散发,而ST11型呈医院内流行.57株细菌都对替加环素耐药,对多黏菌素、米诺环素和多西环素部分敏感.结论 本次泛耐药肺炎克雷们流行主要为ST11型菌株;不同的肺炎克雷伯菌株,播散能力不同;检出泛耐药肺炎克雷伯菌时应增加检测药物的种类.
目的 瞭解華山醫院汎耐藥肺炎剋雷伯菌株及其流行的特點.方法 收集2006年8月-2009年12月對CLSI推薦常規檢測藥物均耐藥的肺炎剋雷們菌臨床分離株,共57株.所有菌株都進行藥物敏感試驗、超廣譜β-內酰胺酶(ESBLs)初篩及錶型確證試驗、改良Hodge試驗、等電聚焦電泳,聚閤酶鏈反應及其產物測序、接閤試驗、腸桿菌基因間重複共有序列PCR(ERIC-PCR)和多位點序列分型(MLST).結果 所有菌株都攜帶blaKPC-2、blaCTX-M-14、blaSHV12和blaTEM-1及qnrB和aac(6')-I b-cr基因.57株細菌中ST423型5株,MIST ST11型52株.ST423型散髮,而ST11型呈醫院內流行.57株細菌都對替加環素耐藥,對多黏菌素、米諾環素和多西環素部分敏感.結論 本次汎耐藥肺炎剋雷們流行主要為ST11型菌株;不同的肺炎剋雷伯菌株,播散能力不同;檢齣汎耐藥肺炎剋雷伯菌時應增加檢測藥物的種類.
목적 료해화산의원범내약폐염극뢰백균주급기류행적특점.방법 수집2006년8월-2009년12월대CLSI추천상규검측약물균내약적폐염극뢰문균림상분리주,공57주.소유균주도진행약물민감시험、초엄보β-내선알매(ESBLs)초사급표형학증시험、개량Hodge시험、등전취초전영,취합매련반응급기산물측서、접합시험、장간균기인간중복공유서렬PCR(ERIC-PCR)화다위점서렬분형(MLST).결과 소유균주도휴대blaKPC-2、blaCTX-M-14、blaSHV12화blaTEM-1급qnrB화aac(6')-I b-cr기인.57주세균중ST423형5주,MIST ST11형52주.ST423형산발,이ST11형정의원내류행.57주세균도대체가배소내약,대다점균소、미낙배소화다서배소부분민감.결론 본차범내약폐염극뢰문류행주요위ST11형균주;불동적폐염극뢰백균주,파산능력불동;검출범내약폐염극뢰백균시응증가검측약물적충류.
Objective To understand the epidemic characteristics of an outbreak of panresistance Klebsiella pneumoniae occurred between 2006 and 2009 in a university hospital of Shanghai, China. Methods A total of 57 panresistance K. pneumoniae isolates were collected from August 2006 to December 2009.Antibiotic susceptibility of the isolates were determined by Kirby-Bauer disc diffusion method and microbroth dilution (MBD). ESBLs-producing initial screen test and phenotypic confirmatory test and carbapenemase-producing modified Hodge test ( MHT) were performed to detect the resistance phenotype of the isolates. Be-ta-lactamases were studied by IEF, PCR and the product sequencing. While conjugation assay were conducted to understand the transferability of these genes. The genetic relationship between isolates was established by ERIC-PCR and multilocus sequence typing (MLST). Except for the antibiotics recommended by CLSI guideline in the routine test, the other antibiotics were added to find out the effective drugs to treat the infection. Results All 57 isolates were highly resistant to all examined antibiotics. All isolates produced ESBLs and carbapenemase. IEF revealed that each isolate produced four beta-lactamases. All isolates carried blaKPC-2,blaCTX-M-14,blaSHV12,blaTEM-1,qnrB and aac(6') - I b-cr. Forty-four of the 57 (77.2% ) isolates were successful to transfer their resistance genes to E. coli recipient J53 by conjugation assay. By RAPD, all 57 isolates were grouped into two genotypes that were further identified as members of MUST types 423 and 11.Sequence types 423(ST423) only occurred before May 2008 and ST11 occurred (52 isolates) after May 2008. Most of isolates of the outbreak were ST11 (91. 2% ). A part of isolates were susceptive to added antibiotics. Conclusion The outbreak of panresistance K.pneumoniae was caused by those isolates which carried multiple resistant genes. There is a different ability of dissemination between different ST types K. pneumoniae isolate. It was necessary to add the antibiotics to find out the effective drugs to treat the infection.